6月12日，Oscar Health盘中上涨5.08%，报29.2639美元/股，成交额1.21亿美元。
消息面上，巴克莱近日将公司评级从"等权重"上调至"跑赢大盘"，目标价从30美元上调至35美元；此前富国银行已于6月初将评级从"跑输大盘"上调至"等权重"，目标价从11美元大幅提高至20美元。连续两家大型投行上调评级，叠加一季度亮眼财报——总收入46.5亿美元同比增长53%，净利润6.79亿美元远超市场预期——持续为股价提供上行动能。自6月初以来，公司股价已从约21美元累计涨幅显著，当前股价已突破巴克莱目标价区间下沿。
Oscar Health是一家以全栈技术平台为核心的医疗保健科技公司，通过ACA提供健康计划，并利用数据和人工智能平台构建差异化会员体验。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.